Publications by authors named "Minxia M He"

Claim this Profile
E
Eloralintide (LY3841136), a novel amylin receptor agonist for the treatment of obesity: From discovery to clinical proof of concept.
Daniel A Briere, Hongchang Qu, Katherine Lansu, Minxia Michelle He, Julie S Moyers, Kieren J Mather

Mol Metab· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolism and Excretion of Therapeutic Peptides: Current Industry Practices, Perspectives, and Recommendations.
Minxia Michelle He, Sean Xiaochun Zhu, Joe R Cannon, Jesper Kammersgaard Christensen, Ruchia Duggal, Adam Hughes, Frank Wesche

Drug Metab Dispos· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic capabilities of cytochrome P450 enzymes in Chinese liver microsomes compared with those in Caucasian liver microsomes.
Junling Yang, Minxia M He, Wei Niu, Steven A Wrighton, Li Li

Br J Clin Pharmacol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The fate of 4-hydroxycarbazole metabolite: metabolism and carcinogenicity assessment of a β-adrenergic receptor modulator containing carbazole structure.
Minxia M He, Tao Ji, Robert J Barbuch, Kristina Campanale, Ron Lantz

Xenobiotica· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of a Beta adrenoceptor modulator and a norepinephrine-serotonin uptake inhibitor for the treatment of obesity.
Cynthia D Jesudason, James E Baker, Robert D Bryant, Jack W Fisher, Libbey S O'Farrell, Minxia M He, Mark L Heiman, Christopher J Rito

ACS Med Chem Lett· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative metabolic capabilities and inhibitory profiles of CYP2D6.1, CYP2D6.10, and CYP2D6.17.
Hongwu Shen, Minxia M He, Houfu Liu, Steven A Wrighton, Li Wang

Drug Metab Dispos· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical pharmacokinetics of alamifovir and its metabolites.
Clark Chan, Eyas Abu-Raddad, Georg Golor, Hikari Watanabe, Akira Sasaki, Minxia M He, Stephen D Wise

Antimicrob Agents Chemother· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of dark liver pigment observed in rats after subchronic dosing of the beta3-adrenergic receptor agonist LY368842.
Minxia M He, Robert J Barbuch, Trent L Abraham, Thomas J Lindsay, David A Jackson

Chem Res Toxicol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolism and disposition of the antihypertensive agent moxonidine in humans.
Minxia M He, Trent L Abraham, Thomas J Lindsay, Hans C Schaefer, Isabelle J Pouliquen, Malcolm I Mitchell

Drug Metab Dispos· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quinidine does not affect the renal clearance of moxonidine.
Stephen D Wise, Clark Chan, Hans G Schaefer, Minxia M He, Isabelle J Pouliquen, Malcolm I Mitchell

Br J Clin Pharmacol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification, synthesis and pharmacological activity of moxonidine metabolites.
David D Wirth, Minxia M He, Boris A Czeskis, Karen M Zimmerman, Ulrike Roettig, Mitchell I Steinberg

Eur J Med Chem· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis